Fixed Price IPO | ₹6 Cr | Listed at BSE SME | Thu, Jun 30, 2016 - Fri, Jul 8, 2016
Kwality Pharmaceuticals IPO is a fixed price issue of ₹6.21 crores. The issue is a combination of fresh issue of 0.02 crore shares aggregating to ₹0.8100 crores and offer for sale of 0.12 crore shares aggregating to ₹5.40 crores.
Kwality Pharmaceuticals IPO bidding started from Jun 30, 2016 and ended on Jul 8, 2016. The shares got listed on BSE SME on Jul 18, 2016.
Kwality Pharmaceuticals IPO price is ₹45 per share. The lot size for an application is 3,000. The minimum amount of investment required by an individual investor (retail) is ₹1,35,000 (3000 shares) (based on upper price). The minimum lot size for investment in HNI is 2 lots (6,000 shares), amounting to ₹2,70,000.
Oneview Corporate Advisors Pvt.Ltd. is the book running lead manager and Bigshare Services Pvt.Ltd. is the registrar of the issue. The Market Maker of the company is Guiness Securities Ltd..
Refer to Kwality Pharmaceuticals IPO RHP for detailed Information.
IPO Open
Thu, Jun 30, 2016
IPO Close
Fri, Jul 8, 2016
Issue Price
₹45 per share
Market Cap (Pre-IPO)
₹23.35 Cr
| IPO Date | 30 Jun to 8 Jul, 2016 |
| Listed on | Mon, Jul 18, 2016 |
| Face Value | ₹10 per share |
| Issue Price | ₹45 per share |
| Lot Size | 3,000 Shares |
| Sale Type | Fresh capital cum OFS |
| Issue Type | Fixed Price IPO |
| Listing At | BSE SME |
| Total Issue Size | 13,80,000 shares (agg. up to ₹6 Cr) |
| Reserved for Market Maker | 72,000 shares Guiness Securities Ltd. (agg. up to ₹0.3240 Cr) |
| Fresh Issue (Ex Market Maker) | 1,08,000 shares (agg. up to ₹0.4860 Cr) |
| Offer for Sale | 12,00,000 shares of ₹10 (agg. up to ₹5 Cr) |
| Net Offered to Public | 13,08,000 shares (agg. up to ₹6 Cr) |
| Share Holding Pre Issue | 50,08,099 shares |
| Share Holding Post Issue | 51,88,099 shares |
| BSE Script Code | 539997 |
| ISIN | INE552U01010 |
Kwality Pharmaceuticals IPO comprises a total issue size of 13,80,000 shares. The net offer to the public is 13,08,000 shares, after excluding 72,000 shares allotted on a firm basis. Of the Net offer 6,54,000 (50.00%) allocated to NII 6,54,000 (50.00%) allocated to RII.
| Investor Category | Shares Offered | % of Net Issue | % of Total Issue |
|---|---|---|---|
| NII (HNI) Shares Offered | 6,54,000 | 50.00% | 47.39% |
| Retail Shares Offered | 6,54,000 | 50.00% | 47.39% |
| Firm Reservations | |||
| Market Maker Shares Offered | 72,000 | 5.22% | |
| Total Shares Offered | 13,80,000 | 100.00% | 100.00% |
Investors can bid for a minimum of 3,000 shares and in multiples thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 3,000 | ₹1,35,000 |
| Retail (Max) | 1 | 3,000 | ₹1,35,000 |
| HNI (Min) | 2 | 6,000 | ₹2,70,000 |
Incorporated in 1983, Kwality Pharmaceuticals Ltd (KPL) is engaged in the business of manufacturing of broad range of finished pharmaceutical formulations in a dosage form. Information in this paragraph is copied from chittorgarh.com.KPL is one of the leading manufacturer & exporters of pharmaceutical formulations in Liquid Orals, Dry Syrups, Tablets, Capsules, Sterile Powder for Injections and small volume injectable. The company has registered all its products in different Countries of Europe, Africa, Asia & CIS Countries.
According to the Company, it has the most modern & sophisticated plant, equipment's, technique and manpower and is working with new SCHEDULE M and W.H.O. norms and certified with GMP and WHO certificate.
| Period Ended |
|---|
| Amount in ₹ Crore |
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Modernisation of the Laboratory | 0.43 |
| 2 | General Corporate Purpose | 0.20 |
| 3 | Offer Expenses | 0.18 |
Sorry, we couldn't find the subscription details. Note that the bidding starts at 10 AM and ends at 5 PM on the days when the public issue is open.
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Offer management fees including fees and reimbursements of Market Making fees (for 3 years) selling commissions, brokerages, and payment to other intermediaries such as Legal Advisors, Registrars and other out of pocket expenses. | 0.39 |
| 2 | Printing & Stationery, Distribution, Postage, etc | 0.03 |
| 3 | Advertisement & Marketing Expenses | 0.03 |
| 4 | Regulatory & other expenses | 0.03 |
| Price Details | BSE SME |
|---|---|
| Final Issue Price | ₹45.00 |
| Open | ₹45.00 |
| Low | ₹43.00 |
| High | ₹45.80 |
| Last Trade | ₹44.50 |
Lead Manager Reports
Kwality Pharmaceuticals IPO is a SME IPO of 13,80,000 equity shares of the face value of ₹10 aggregating up to ₹6 Crores. The issue is priced at ₹45 per share. The minimum order quantity is 3000.
The IPO opens on Thu, Jun 30, 2016, and closes on Fri, Jul 8, 2016.
Bigshare Services Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE SME.
Zerodha customers can apply online in Kwality Pharmaceuticals IPO using UPI as a payment gateway. Zerodha customers can apply in Kwality Pharmaceuticals IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Kwality Pharmaceuticals IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Kwality Pharmaceuticals IPO opens on Thu, Jun 30, 2016 and closes on Fri, Jul 8, 2016.
Kwality Pharmaceuticals IPO lot size is 3000, and the minimum amount required for application is ₹1,35,000.
You can apply in Kwality Pharmaceuticals IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Kwality Pharmaceuticals IPO will be done on [.], and the allotted shares will be credited to your demat account by . Check the Kwality Pharmaceuticals IPO allotment status.
The Kwality Pharmaceuticals IPO listing date is on Mon, Jul 18, 2016.
